- Trials with a EudraCT protocol (61)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
61 result(s) found for: Community Pharmacy.
Displaying page 1 of 4.
EudraCT Number: 2007-000599-18 | Sponsor Protocol Number: P903-09 | Start Date*: 2008-03-25 | |||||||||||
Sponsor Name:Cerexa, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline versus Ceftriaxone in the Treatment of Adult Subjects with Community-Acquired ... | |||||||||||||
Medical condition: Adult Subjects with Community-Acquired Pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) DE (Completed) HU (Completed) AT (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000598-41 | Sponsor Protocol Number: P903-08 A4 | Start Date*: 2007-11-22 | |||||||||||
Sponsor Name:Cerexa, Inc. | |||||||||||||
Full Title: "A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline versus Ceftriaxone, with Adjunctive Clarithromycin, in the Treatment of Adult... | |||||||||||||
Medical condition: Adults Subjects with Community-Acquired Pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) ES (Completed) AT (Completed) LT (Completed) EE (Completed) SK (Completed) BG (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003971-20 | Sponsor Protocol Number: CE01-300 | Start Date*: 2013-05-07 | |||||||||||
Sponsor Name:Cempra Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in the Treatment of Adult Patients with Community-Ac... | |||||||||||||
Medical condition: Community-Acquired Bacterial Pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) ES (Completed) PL (Completed) LV (Completed) EE (Completed) BG (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000835-84 | Sponsor Protocol Number: 30982081-CAP-3001 | Start Date*: 2006-10-10 | |||||||||||
Sponsor Name:Jansen-Cilag International N.V. | |||||||||||||
Full Title: Randomized, Double-Blind, Multicenter Study of Ceftobiprole Medocaril Versus Ceftriaxone with/without Linezolid in Treatment of Subjects Hospitalized With Community-Acquired Pneumonia | |||||||||||||
Medical condition: Hospitalized community acquired pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) LT (Completed) HU (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002683-32 | Sponsor Protocol Number: DUR001-305 | Start Date*: 2015-03-30 | |||||||||||
Sponsor Name:Durata Therapeutics International B.V. | |||||||||||||
Full Title: A Phase 3, double-blinded, randomized, comparator trial of the safety and efficacy of a single dose of dalbavancin to twice daily linezolid for the treatment of community acquired bacterial pneumonia | |||||||||||||
Medical condition: Community acquired bacterial pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003026-14 | Sponsor Protocol Number: ML-3341-306 | Start Date*: 2016-02-04 | |||||||||||
Sponsor Name:Melinta Therapeutics, Inc. | |||||||||||||
Full Title: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF INTRAVENOUS TO ORAL DELAFLOXACIN IN ADULT SUBJECTS WITH COMMUNITY-ACQUIRED BACTE... | |||||||||||||
Medical condition: Community-Acquired Bacterial Pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) ES (Completed) LV (Completed) BG (Completed) DE (Completed) SI (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002110-35 | Sponsor Protocol Number: CL06-001 | Start Date*: 2006-08-24 | |||||||||||
Sponsor Name:Advanced Life Sciences | |||||||||||||
Full Title: A Double-Blinded, Randomized, Parallel group, Multi-Centre, Multi-National Comparative Study of the Safety and Efficacy of Cethromycin 300mg QD to Clarithromycin (KLACIDĀ®) 250mg BID for the treatme... | |||||||||||||
Medical condition: Community Acquired Pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) EE (Completed) DE (Completed) HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002986-32 | Sponsor Protocol Number: PTK0796-CABP-19302 | Start Date*: 2020-10-26 | |||||||||||
Sponsor Name:Paratek Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3b Randomized, Double-Blind, Multi-Center Study to Compare the Safety and Efficacy of Omadacycline IV/PO to Moxifloxacin IV/PO for Treating Adult Subjects with Community-Acquired Bacterial ... | |||||||||||||
Medical condition: Community-Acquired Bacterial Pneumonia (CABP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Ongoing) HR (Ongoing) HU (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002182-35 | Sponsor Protocol Number: P903-25 | Start Date*: 2012-10-22 | |||||||||||
Sponsor Name:Cerexa, Inc. (subsidiary of Forest Laboratories) | |||||||||||||
Full Title: A Multicenter, Multinational, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Ceftaroline fosamil Versus Ceftriaxone Plus Vancomycin in Adult Subjects with Community-acquired ... | |||||||||||||
Medical condition: Community-acquired bacterial pneumonia (CABP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) HU (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003453-13 | Sponsor Protocol Number: CE01-301 | Start Date*: 2014-06-18 | |||||||||||
Sponsor Name:Cempra Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in the Treatment of Ad... | |||||||||||||
Medical condition: Community-Acquired Bacterial Pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BG (Completed) LV (Completed) DE (Completed) ES (Completed) RO (Completed) SK (Completed) NL (Completed) SI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004071-13 | Sponsor Protocol Number: PTK0796-CABP-1200 | Start Date*: 2015-05-20 | |||||||||||
Sponsor Name:Paratek Pharma LLC | |||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Multi-Center Study to Compare the Safety and Efficacy of Omadacycline IV/PO to Moxifloxacin IV/PO for Treating Adult Subjects with Community-Acquired Bacterial P... | |||||||||||||
Medical condition: Community-Acquired Bacterial Pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) HU (Completed) CZ (Completed) LV (Completed) DE (Completed) ES (Completed) BE (Completed) PL (Prematurely Ended) GR (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000736-37 | Sponsor Protocol Number: 1001 | Start Date*: 2022-08-12 | ||||||||||||||||
Sponsor Name:Biotest AG | ||||||||||||||||||
Full Title: A randomized, placebo-controlled, double-blind, multi-center, phase III trial to assess the efficacy and safety of trimodulin (BT588) in adult hospitalized subjects with CAP including COVID-19 pneu... | ||||||||||||||||||
Medical condition: non-severe community-acquired pneumonia (CAP) or moderate or severe Coronavirus Disease 2019 (COVID-19) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) ES (Prematurely Ended) HU (Completed) AT (Ongoing) BE (Ongoing) LV (Ongoing) LT (Ongoing) PT (Ongoing) SK (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004615-45 | Sponsor Protocol Number: BPR-PIP-002 | Start Date*: 2016-12-02 | ||||||||||||||||
Sponsor Name:Basilea Pharmaceutica International Ltd | ||||||||||||||||||
Full Title: A multicentre, randomized, investigator-blind, active-controlled study to evaluate the safety, tolerability, pharmacokinetics and efficacy of ceftobiprole versus intravenous standard-of-care cephal... | ||||||||||||||||||
Medical condition: Hospital-acquired pneumonia or community-acquired pneumonia requiring hospitalisation. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) BG (Completed) Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-004039-37 | Sponsor Protocol Number: CE01-203 | Start Date*: 2014-10-10 |
Sponsor Name:Cempra Pharmaceuticals, Inc. | ||
Full Title: A Phase 2/3, Randomised, Partly blinded (blinded investigator), Multi-center, Comparative Study to Determine the Safety and activity of Solithromycin (Intravenous and oral) in paediatric patients ... | ||
Medical condition: suspected or confirmed community acquired bacterial pneuumonia (CABP) | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA GB (Completed) HU (Completed) ES (Temporarily Halted) | ||
Trial results: View results |
EudraCT Number: 2004-002798-21 | Sponsor Protocol Number: WI18273 | Start Date*: 2005-02-18 |
Sponsor Name:F.Hoffmann-La Roche Ltd | ||
Full Title: A Phase II, prospective, randomized, double-blind, active-controlled, parallel group, multi-center 'proof of concept' trial in adult patients with community-acquired pneumonia requiring hospitaliza... | ||
Medical condition: Community-acquired pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) HU (Completed) SK (Completed) LT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000058-35 | Sponsor Protocol Number: A7801002 | Start Date*: 2006-04-26 |
Sponsor Name:Pfizer Consumer Healthcare Comm. VA/SCA | ||
Full Title: A community pharmacy based investigation in the self-medication area Efficacy and safety of SinutabĀ® [Paracetamol (500mg) and Pseudoephedrine (30mg)] on subjects with nasal congestion accompanied ... | ||
Medical condition: The medical rationale = to investigate this combination drug in the symptomatic relief of common cold with nasal symptoms. The reduction of symptom severity may allow subjects receiving active medi... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002203-18 | Sponsor Protocol Number: P903-31 | Start Date*: 2012-07-18 | ||||||||||||||||||||||||||
Sponsor Name:Cerexa, Inc. (subsidary of Forest Laboratories) | ||||||||||||||||||||||||||||
Full Title: A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ceftaroline Versus Ceftriaxone in Pediatric Subjects With... | ||||||||||||||||||||||||||||
Medical condition: Community-acquired Bacterial Pneumonia | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: Outside EU/EEA HU (Completed) GR (Completed) ES (Completed) PL (Completed) BG (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-001637-41 | Sponsor Protocol Number: A7801001 | Start Date*: 2005-07-26 |
Sponsor Name:Pfizer Consumer Healthcare cva/sca | ||
Full Title: A community pharmacy based investigation in the self-medication area Efficacy and safety of SinutabĀ® (Paracetamol (500mg)/Pseudoephedrine (30mg)) on subjects with nasal congestion accompanied by h... | ||
Medical condition: Medical rationale= Investigation of combination drug Sinutab in symptomatic relief of common cold with nasal symptoms. Community pharmacists are considered as local investigators including subjec... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002340-14 | Sponsor Protocol Number: REMAP-CAP | Start Date*: 2015-09-16 | ||||||||||||||||
Sponsor Name:University Medical Center Utrecht | ||||||||||||||||||
Full Title: Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP). (COVID-19) | ||||||||||||||||||
Medical condition: Severe Community Acquired Pneumonia COVID-19 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) IE (Trial now transitioned) PT (Trial now transitioned) GB (GB - no longer in EU/EEA) HU (Ongoing) BE (Trial now transitioned) DE (Ongoing) HR (Ongoing) ES (Temporarily Halted) FR (Trial now transitioned) FI (Ongoing) IT (Ongoing) CZ (Trial now transitioned) SI (Ongoing) RO (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021574-11 | Sponsor Protocol Number: 32729463CAP2001 | Start Date*: 2011-01-24 | |||||||||||
Sponsor Name:Furiex Pharmaceuticals, Inc | |||||||||||||
Full Title: A Randomized, Controlled, Double-Blind, Multicenter, Phase 2 Study of the Safety/Tolerability and Efficacy of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospita... | |||||||||||||
Medical condition: Community-Acquired Bacterial Pneumonia (CABP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.